-
Recent Posts
- Nonlinear mixed effect modeling – a bed time story
- Export control in a digital world – is synthetic data the future for clinical studies?
- Neural ODEs vs ODEs – what’s the difference?
- ScienceJournalJourney3 – the translation problem in drug development
- ScienceJournalJourney2 – The one surprising use of Fexofenadine (Telfast)
Recent Comments
Archives
Categories
Meta
Tag Archives: high throughput screening
A sticky situation
Researchers, if your compound Has strong noncompetitive inhibition Has an unusually steep dose response curve Exhibits time dependent inhibition Does not have clear structure-activity relationships It’s not your next big hit. It could be an aggregator instead. These are some … Continue reading